| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 16, 2010Partnerships with American College of Cardiology and Association of Black Cardiologists and Latest Data from IMPROVE HF Clinical Study All Aim to Drive Equitable Treatment
MINNEAPOLIS & ATLANTA, Mar 16, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today introduced Every Patient First, a health equity initiative that, in partnership with health care providers,...
-
Mar 15, 2010Safety and Effectiveness Trial Evaluated the Arctic Front(R) Cardiac CryoAblation Catheter System for the Treatment of Paroxysmal Atrial Fibrillation
MINNEAPOLIS & ATLANTA, Mar 15, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced data from the STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial...
-
Mar 14, 2010Independent Analysis of Large and Comprehensive ENDEAVOR Program Shows Remarkably Durable Safety and Efficacy at Five Years of Follow Up in Coronary Artery Disease Patients
MINNEAPOLIS & ALTANTA, Mar 14, 2010 (BUSINESS WIRE) -- The consistency and quality of the long-term clinical results for the Endeavor(R) drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT),...
-
Mar 12, 2010
MINNEAPOLIS, Mar 12, 2010 (BUSINESS WIRE) -- The U.S. Food and Drug Administration (FDA) Neurological Devices Panel today voted seven to five to recommend approval with conditions of Deep Brain...
-
Mar 4, 2010
Company Recognized for Ground-Breaking Work in the Field of Deep Brain Stimulation Medtronic, Inc. (NYSE: MDT) today announced that it has been selected as one of Massachusetts Institute of Technology
-
Mar 3, 2010Corporate Responsibility Magazine lists Medtronic among 2010's 100 Best Corporate Citizens
NEW YORK, Mar 03, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) was named today to the 11th annual "100 Best Corporate Citizens List" published by Corporate Responsibility magazine (formerly...
-
Mar 2, 2010
MINNEAPOLIS, Mar 02, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), today announced it will participate in the 30th Annual Cowen and Company Health Care Conference on Tuesday, March 9, 2010,...
-
Feb 23, 2010
MINNEAPOLIS, Feb 24, 2010 (BUSINESS WIRE) -- Medtronic, Inc., (NYSE: MDT), today announced William A. Hawkins, chairman and CEO, has been elected a Fellow of the American Institute of Medical and...
-
Feb 18, 2010
MINNEAPOLIS, Feb 18, 2010 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE:MDT), today approved a cash dividend of $0.205 per share of the company's common stock. The dividend is...
-
Feb 10, 2010Consistent With Lower Court Ruling, Latest Legal Decision Enables Uninterrupted Access to Leading Transcatheter Heart Valve in Germany
MINNEAPOLIS, Feb 11, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), announced today that an appeals court in Germany has found that the CoreValve(R) transcatheter aortic valve system does...
-
Feb 5, 2010Study Presented at the Combined Sections Meetings of the Triological Society, the most prestigious society in Otolaryngology, received the John J. Conley Resident Research Award (Eastern Section)
MINNEAPOLIS, Feb 05, 2010 (BUSINESS WIRE) -- Results of a clinical study presented Thursday, Feb. 4 at the annual Triological Society meetings in Orlando, Fla., suggest a sterile barrier sheath...
-
Jan 28, 2010First Release of STOP-AF Data on Medtronic Arctic Front(R) Cryoballoon for Paroxysmal Atrial Fibrillation Patients
MINNEAPOLIS, Jan 28, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today pivotal data for the Medtronic Arctic Front(R) CryoAblation Catheter System will be presented as a late...
-
Jan 25, 2010Acquisition Will Expand Product Offering and Pipeline for Cardiovascular Interventions
MINNEAPOLIS, Jan 25, 2010 (BUSINESS WIRE) -- Moving to expand its impact on peripheral vascular disease,Medtronic, Inc. (NYSE:MDT), announced today that it has signed a definitive agreement to...
-
Jan 25, 2010Melody(R) Transcatheter Pulmonary Valve Offers Non-Surgical Valve Replacement Option for Congenital Heart Disease Patients
MINNEAPOLIS, Jan 25, 2010 (BUSINESS WIRE) -- In a significant development for congenital heart disease patients, Medtronic, Inc. (NYSE: MDT), announced today that its Melody(R) Transcatheter...
-
Jan 19, 2010"Global Heroes" Will Receive Entry and Travel to the Medtronic Twin Cities Marathon or Medtronic TC 10 Mile in October
MINNEAPOLIS, Jan 19, 2010 (BUSINESS WIRE) -- Medtronic (NYSE: MDT) announced today it is recruiting runners from around the world who benefit from medical technology to participate in the fifth...
-
Jan 4, 2010
MINNEAPOLIS, Jan 04, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), today announced it will participate in the 28th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 11, 2010, in San...
-
Dec 18, 2009
MEMPHIS, Tenn., Dec 18, 2009 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of the SOVEREIGN(TM) Spinal System. The SOVEREIGN Spinal System is an intervertebral...
-
Dec 8, 2009MEDTRONIC HIRES RENOWNED CARDIOLOGIST AS VICE PRESIDENT OF MEDICAL AFFAIRS FOR CORONARY AND PERIPHERAL BUSINESS
Researcher, Educator and Innovator Prof. Martin Rothman Assumes New Role with Industry Following 37 Years of Clinical Practice Medtronic, Inc. (NYSE: MDT), today announced the hire of Prof. Martin...
-
Dec 6, 2009Ongoing Research Focuses on Optimizing DBS Therapy for Patients
MINNEAPOLIS--(BUSINESS WIRE)--Dec. 6, 2009-- Long-term data from an investigational study of Deep Brain Stimulation (DBS) Therapy for Epilepsy was released this week by Medtronic, Inc. (NYSE:MDT)...
-
Dec 3, 2009
MINNEAPOLIS--(BUSINESS WIRE)--Dec. 3, 2009-- The board of directors of Medtronic, Inc. (NYSE:MDT), today approved a cash dividend of $0.205 per share of the company’s common stock. The dividend...
-
Dec 2, 2009
MINNEAPOLIS--(BUSINESS WIRE)--Dec. 2, 2009-- Medtronic, Inc. (NYSE:MDT), today announced the appointment of Michael J. Coyle as executive vice president and group president of its Cardiology...
-
Nov 29, 2009
MINNEAPOLIS & SAN ANTONIO--(BUSINESS WIRE)--Nov. 17, 2009-- Medtronic, Inc. (NYSE:MDT) today announced the grand opening of its new Diabetes Therapy Management and Education Center in San Antonio....
-
Nov 25, 2009
MINNEAPOLIS--(BUSINESS WIRE)--Nov. 25, 2009-- Medtronic, Inc. (NYSE:MDT), the world’s leading medical technology company, today announced it will participate in the 21st Annual Piper Jaffray...
-
Nov 24, 2009Non-GAAP diluted EPS of $0.77 grew 15%; GAAP diluted EPS of $0.78 grew 63%
MINNEAPOLIS--(BUSINESS WIRE)--Nov. 24, 2009-- Medtronic, Inc. (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2010, which ended Oct. 30, 2009. The company...
-
Nov 19, 2009
MINNEAPOLIS--(BUSINESS WIRE)--Nov. 19, 2009-- Medtronic, Inc. received today an International Business Leadership Award from the Greater Miami Chamber of Commerce in recognition for its...
-
Nov 19, 2009Global Partnership with Vital Images Leverages Advanced Visualization Technology to Streamline Pre-Case Planning through Patient Follow-Up
MINNEAPOLIS--(BUSINESS WIRE)--Nov. 19, 2009-- Continuing to drive innovation in endovascular aortic repair (EVAR), Medtronic, Inc. (NYSE: MDT), today announced the introduction of an imaging and...
-
Nov 19, 2009Company Applauds Leadership of Sens. Dianne Feinstein and Barbara Boxer, Governor Arnold Schwarzenegger, Representative Anna Eshoo and the California Congressional Delegation
MINNEAPOLIS, Nov 19, 2009 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), chairman and CEO Bill Hawkins today issued the following statement regarding the U.S. Senate's revised proposal regarding...
-
Nov 18, 2009FDA Noted that the Company’s Promised Corrective Actions Appear to be Adequate to Resolve the Issues Raised in the Letter
MINNEAPOLIS--(BUSINESS WIRE)--Nov. 18, 2009-- Medtronic (NYSE: MDT) today announced it received a warning letter from the U.S. Food and Drug Administration (FDA) regarding the inspection of the...
-
Nov 17, 2009A Spinal System That Offers Two Screw Designs for Enhanced Fixation
MEMPHIS, Tenn.--(BUSINESS WIRE)--Nov. 17, 2009-- Medtronic, Inc. (NYSE: MDT), today announced the launch of the TSRH® 3Dx™ Spinal System. Designed with procedural efficiency in mind, the TSRH...
-
Nov 15, 2009Early Results Show Preserved Heart Size in Pacemaker Patients with Normal Left Ventricles
MINNEAPOLIS & ORLANDO, Fla.--(BUSINESS WIRE)--Nov. 15, 2009-- Pacing the two lower chambers of the heart, or bi-ventricular pacing, prevented cardiac enlargement as compared to only pacing the...
-
Nov 13, 2009On World Diabetes Day, Medtronic Highlights the Growing Clinical Evidence for the Benefits of Continuous Glucose Monitoring in Diabetes Control
MINNEAPOLIS--(BUSINESS WIRE)--Nov. 13, 2009-- In acknowledgement of this year’s World Diabetes Day, which calls on all those responsible for diabetes care to understand diabetes and take...
-
Aug 22, 2006
MINNEAPOLIS--(BUSINESS WIRE)--Aug. 22, 2006--Medtronic, Inc. (NYSE:MDT): -- Reported earnings of $599 million and diluted EPS of $0.51 grew 87% and 96%, respectively over the prior year's quarter....
-
May 23, 2006
MINNEAPOLIS--(BUSINESS WIRE)--May 23, 2006--Medtronic, Inc. (NYSE:MDT): Annual Revenue of $11.3 Billion Grew 12% (13% Constant Currency Growth); Fourth Quarter Revenue of $3.1 Billion Grew 11%...
-
Nov 16, 2005
MINNEAPOLIS--(BUSINESS WIRE)--Nov. 16, 2005--Medtronic, Inc. (NYSE:MDT): -- Implantable Cardioverter Defibrillator (ICD) Revenues Grew 34%; Worldwide Market Share Continued to Increase -- Spinal...
-
May 24, 2005
Medtronic, Inc. (NYSE:MDT): -- Implantable Cardioverter Defibrillator (ICD) Revenues of $682 million in the Quarter Increases Medtronic Worldwide ICD Market Share to 50 Percent -- Spinal Business...
-
Aug 18, 2004
MINNEAPOLIS--(BUSINESS WIRE)--Aug. 18, 2004-- Broad Based Growth Was Led By 31 Percent Increase In Quarterly Implantable Defibrillator Revenues Medtronic, Inc. (NYSE:MDT) today announced quarterly...
-
May 4, 2004
MINNEAPOLIS--(BUSINESS WIRE)--May 24, 2004--Medtronic, Inc. (NYSE:MDT) today announced record quarterly revenues of $2.665 billion, an increase of 24.1 percent over the $2.148 billion of the...
-
Feb 10, 2004
MINNEAPOLIS--(BUSINESS WIRE)--Feb. 11, 2004-- Record Quarterly Performance Led by Greater Than 15 Percent Growth in Spinal, Implantable Defibrillators, Diabetes and Vascular Drawing upon the...
-
Nov 12, 2003
MINNEAPOLIS--(BUSINESS WIRE)--Nov. 12, 2003-- Record Quarter Led by Continued Strong Growth in Implantable Defibrillator and Spinal Revenues, Together With Accelerated Growth in Diabetes; All...
-
Aug 12, 2003
MINNEAPOLIS--(BUSINESS WIRE)--Aug. 12, 2003-- Continued Strong Performances in Cardiac Rhythm Management, Spinal and Neurological Spur Growth Continuing to benefit from widespread acceptance of...
-
Nov 17, 2001Spinal Products and Implantable Defibrillators, Two of Medtronic's Largest Product Lines, Led Second-Quarter Growth
MINNEAPOLIS, Nov 17, 2004 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced quarterly net earnings of $535.7 million, or $0.44 per diluted share, an increase of 13 percent over the...